Statements (20)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:naproxen
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
M01AE02
|
| gptkbp:brand |
gptkb:naproxen
|
| gptkbp:contraindication |
active gastrointestinal bleeding
allergy to NSAIDs |
| gptkbp:drugClass |
nonsteroidal anti-inflammatory drug
|
| gptkbp:form |
extended-release tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Naprelan
|
| gptkbp:manufacturer |
Almatica Pharma
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
headache stomach upset |
| gptkbp:usedFor |
pain relief
inflammation |
| gptkbp:bfsParent |
gptkb:naproxen
|
| gptkbp:bfsLayer |
7
|